LLY | Eli Lilly & Co. | $1.3t | $1442.76 | -0.2% | 1.5M |
AZN | AstraZeneca PLC | $285.2b | $184.85 | +0.1% | 999.2K |
MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | $9.2b | $423.67 | -1.0% | 195.8K |
PTGX | Protagonist Therapeutics, Inc | $9.1b | $125.03 | -4.0% | 170.8K |
KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $7.3b | $95.16 | -1.2% | 166.2K |
TERN | Terns Pharmaceuticals, Inc. Common Stock | $6.1b | $52.97 | +0.0% | 2.3M |
TVTX | Travere Therapeutics, Inc. Common Stock | $4.7b | $49.84 | -1.5% | 386.6K |
VKTX | Viking Therapeutics, Inc | $3.3b | $26.83 | -8.2% | 1.8M |
MBX | MBX Biosciences, Inc. Common Stock | $2.6b | $53.49 | -4.3% | 121.2K |
NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $2.4b | $19.80 | -1.2% | 490.8K |
SEPN | Septerna, Inc. Common Stock | $2.0b | $41.55 | -2.4% | 177.3K |
MAZE | Maze Therapeutics, Inc. Common Stock | $1.8b | $34.26 | -0.3% | 268.7K |
KLRA | Kailera Therapeutics, Inc. Common Stock | $1.7b | $12.65 | -4.4% | 637.5K |
MLYS | Mineralys Therapeutics, Inc. Common Stock | $1.4b | $14.78 | -3.5% | 324.1K |
MNKD | Mannkind Corporation | $1.2b | $3.92 | -4.2% | 1.3M |
KARD | Kardigan, Inc. Common Stock | $1.2b | $12.77 | -7.5% | 181.9K |
ESPR | Esperion Therapeutics, Inc. | $0.8b | $3.19 | 0.0% | N/A |
SGMT | Sagimet Biosciences Inc. Series A Common Stock | $0.7b | $10.20 | -0.0% | 307.8K |
LXRX | Lexicon Pharmaceuticals, Inc. | $0.6b | $1.75 | -2.8% | 523.2K |
GYRE | Gyre Therapeutics, Inc. Common Stock | $470.8m | $4.63 | +7.9% | 280.6K |
ALT | Altimmune, Inc. Common Stock | $396.8m | $1.57 | -3.6% | 3.8M |
RZLT | Rezolute, Inc. Common Stock (NV) | $387.9m | $3.52 | -4.0% | 3.0M |
BIOA | BioAge Labs, Inc. Common Stock | $273.5m | $5.11 | -7.2% | 272.4K |
ORMP | Oramed Pharmaceuticals Inc. | $166.4m | $3.90 | +5.7% | 251.5K |
CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $127.6m | $0.96 | -2.6% | 159.2K |
VANI | Vivani Medical, Inc. Common Stock (DE) | $94.7m | $1.02 | +1.5% | 365.6K |
MIST | Milestone Pharmaceuticals Inc. Common Shares | $94.5m | $0.43 | -14.9% | 4.4M |
VTVT | vTv Therapeutics Inc. Class A Common Stock | $93.1m | $17.48 | -8.8% | 12.3K |
TENX | Tenax Therapeutics, Inc. | $68.9m | $1.48 | -8.6% | 502.4K |
BMEA | Biomea Fusion, Inc. Common Stock | $45.2m | $0.53 | -10.7% | 378.2K |
GRDX | GridAI Technologies Corp. Common Stock | $42.9m | $3.33 | -2.4% | 278.4K |
VERU | Veru Inc. | $36.8m | $2.11 | -1.7% | 66.5K |
ALGS | Aligos Therapeutics, Inc. Common Stock | $29.7m | $1.71 | -17.1% | 96.2K |
AARD | Aardvark Therapeutics, Inc. Common Stock | $26.9m | $1.26 | -3.0% | 147.3K |
NCEL | NewcelX Ltd. Ordinary Shares | $15.2m | $2.73 | +2.9% | 5.4K |
LPCN | Lipocine Inc. | $12.0m | $1.64 | -2.3% | 87.3K |
GUTS | Fractyl Health, Inc. Common Stock | $11.9m | $1.02 | +12.9% | 570.5K |
CURX | Curanex Pharmaceuticals Inc Common Stock | $9.7m | $4.66 | 0.0% | 3.5K |
MTVA | MetaVia Inc. Common Stock | $8.3m | $1.27 | -3.1% | 39.3K |
SKYE | Skye Bioscience, Inc. Common Stock | $5.4m | $1.16 | +0.9% | 44.0K |
TCRT | Alaunos Therapeutics, Inc. Common Stock | $4.7m | $1.60 | -1.8% | 52.3K |
GLMD | Galmed Pharmaceuticals Ltd. | $4.3m | $4.59 | 0.0% | N/A |
CVKD | Cadrenal Therapeutics, Inc. Common Stock | $4.0m | $1.48 | -3.0% | 60.9K |
ELAB | PMGC Holdings Inc. Common Stock | $1.6m | $1.77 | +7.6% | 1.3M |